[1]
“Evaluating the Efficacy and Safety of Bimekizumab for Plaque Psoriasis and Psoriatic Arthritis: An Expert Consensus Panel Report”, J of Skin, vol. 8, no. 2, pp. 1348–1364, Mar. 2024, doi: 10.25251/skin.8.2.1.